Longitudinally Extensive Transverse Myelitis in Autoimmune Connective Tissue Diseases: A Comprehensive Review. [PDF]
R GS, K N.
europepmc +1 more source
Editorial: Antibody-mediated thrombotic disease. [PDF]
Halkidis K, Liu S, Chaturvedi S.
europepmc +1 more source
Longitudinal profiling of antiphospholipid antibodies reveals pre-conception levels as a key predictor of live birth in women with recurrent pregnancy loss. [PDF]
Luo PD, Li Q, Wei SQ, Zheng PS.
europepmc +1 more source
Do Patients with Antiphospholipid Syndrome Present with More Significant Venous Thromboembolic Clot Burden? A Retrospective Single-Center Study. [PDF]
Liput J +6 more
europepmc +1 more source
Persistent thrombotic events in a seronegative patient with antiphospholipid syndrome. [PDF]
Saeed SM +4 more
europepmc +1 more source
Heparin protocols in cardiovascular surgery for antiphospholipid syndrome: a clinical case report. [PDF]
Nakajima T +6 more
europepmc +1 more source
A Diagnostic Tightrope: Carbimazole-Induced Microscopic Polyangiitis With Co-Existent Antiphospholipid Syndrome and Diffuse Alveolar Hemorrhage. [PDF]
Thulasinadh P +3 more
europepmc +1 more source
Related searches:
Antiphospholipid antibodies and the antiphospholipid antibody syndrome
Drugs of Today, 2000The antiphospholipid antibody syndrome is a multisystem disorder characterized by persistently elevated antiphospholipid antibodies and/or arterial or venous thrombosis, thrombocytopenia and recurrent spontaneous abortion. Anticardiolipin antibodies and the lupus anticoagulant are different classes of antiphospholipid antibodies associated with this ...
G T, Nahass, S L, Jensen
openaire +2 more sources
This review has focused on some recent developments which have begun to define the immunologic specificity of aPL antibodies. These studies have revealed that these immunoglobulins are more complex than has been realised to date and, more importantly, they offer new approaches to investigate how the prothrombotic diathesis associated with aPL ...
H P, McNeil, S A, Krilis
openaire +2 more sources
Antiphospholipid syndrome, antiphospholipid antibodies, and stroke
International Journal of Stroke, 2023Antiphospholipid syndrome (APS) is a prothrombotic autoimmune disease with heterogeneous clinicopathological manifestations and is a well-established cause of acute ischemic stroke (AIS) and transient ischemic attack (TIA), particularly in younger patients.
Prabal Mittal +5 more
openaire +2 more sources

